KR20020048778A - Alismatis Rhizoma fermented wine and process for prepatration therof - Google Patents

Alismatis Rhizoma fermented wine and process for prepatration therof Download PDF

Info

Publication number
KR20020048778A
KR20020048778A KR1020000078051A KR20000078051A KR20020048778A KR 20020048778 A KR20020048778 A KR 20020048778A KR 1020000078051 A KR1020000078051 A KR 1020000078051A KR 20000078051 A KR20000078051 A KR 20000078051A KR 20020048778 A KR20020048778 A KR 20020048778A
Authority
KR
South Korea
Prior art keywords
extract
fermentation
taxa
present
water
Prior art date
Application number
KR1020000078051A
Other languages
Korean (ko)
Inventor
서권일
조영숙
박정로
이성태
박채규
이종원
Original Assignee
서권일
신준식
조영숙
순천시
박정로
이성태
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서권일, 신준식, 조영숙, 순천시, 박정로, 이성태 filed Critical 서권일
Priority to KR1020000078051A priority Critical patent/KR20020048778A/en
Publication of KR20020048778A publication Critical patent/KR20020048778A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12GWINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00Preparation of other alcoholic beverages
    • C12G3/02Preparation of other alcoholic beverages by fermentation
    • C12G3/026Preparation of other alcoholic beverages by fermentation with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides, added before or during the fermentation stage; with flavouring ingredients added before or during the fermentation stage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12GWINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00Preparation of other alcoholic beverages
    • C12G3/04Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
    • C12G3/06Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with flavouring ingredients
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12HPASTEURISATION, STERILISATION, PRESERVATION, PURIFICATION, CLARIFICATION OR AGEING OF ALCOHOLIC BEVERAGES; METHODS FOR ALTERING THE ALCOHOL CONTENT OF FERMENTED SOLUTIONS OR ALCOHOLIC BEVERAGES
    • C12H1/00Pasteurisation, sterilisation, preservation, purification, clarification, or ageing of alcoholic beverages
    • C12H1/02Pasteurisation, sterilisation, preservation, purification, clarification, or ageing of alcoholic beverages combined with removal of precipitate or added materials, e.g. adsorption material
    • C12H1/06Precipitation by physical means, e.g. by irradiation, vibrations
    • C12H1/063Separation by filtration

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE: Provided is Alismatis Rhizoma fermented wine which has excellent aroma and color and its preparation process. Alismatis Rhizoma has excellent antibacterial activity, antioxidation effect and immuno activity. CONSTITUTION: The manufacturing method comprises the steps of; soaking rice in water then steaming it; inoculating Aspergillus awamori thereinto then culturing them at 30-55 deg.C to manufacture koji; supplying water to the koji then followed by inoculating yeast into and fermenting it to prepare raw spirit; soaking Alismatis Rhizoma then steaming it: mixing the steamed Alismatis Rhizoma with the first-fermentate and water; fermenting the mixture at 20-40 deg.C then followed by filtering and sterilizing it; and adding sugar thereto at 2-7%.

Description

택사발효주 및 그 제조방법{Alismatis Rhizoma fermented wine and process for prepatration therof}Taxus fermented wine and its manufacturing method {Alismatis Rhizoma fermented wine and process for prepatration therof}

본 발명은 택사발효주 및 그 제조방법에 관한 것이다. 더욱 상세하게는, 본 발명은 흑국균을 배양한 다음 주모를 제조하여 항균활성, 항산화 효과 및 면역활성효과가 있는 택사에 접종하고 알콜발효하여 제조한 색과 향 및 맛이 우수한 택사발효주 및 그 제조방법에 관한 것이다.The present invention relates to a taxi fermentation wine and a method for producing the same. More specifically, the present invention incubated with black bacteria, and then prepared a jumogi inoculated in the taxis having antimicrobial, antioxidant and immuno-activating effect, and the fermentation of liquor fermented with excellent color, flavor and taste produced by alcohol fermentation and its preparation It is about a method.

택사과(澤瀉科;Alismataceae)식물인 택사(Alismatis Rhizoma)는 단자엽 식물중 진화하는 과정에서 분화된 잔존군으로 세계적으로 약 13속 90여종이 분포되어 있는데, 중국의 복건, 강서 사천, 귀천 및 운남지방에서도 많이 생산되고 있으며, 우리나라의 경우에는 그 생산량의 50% 이상을 차지하고 있는 전남 순천 지방을 비롯하여 전남 무안, 구례 및 경북 상주 지역에서 생산되고 있으며, 생약으로 쓰이는 택사는 질경이 택사(Alisma plantago-aquatica L. var. orientaleSamuels)가 주로 재배 생산된다. 택사의 함유성분은 전분 25%, 단백질 7%, 정유의 furfural, resin, 무기염과 triterpenoid계의 alisol A, B, C와 그 아세테이트(acetate) 및 당류로 알려져 있다. 이와 같은 택사는 예로부터 수분을 제거하고 오장을 도우며 기력을 튼튼히 하는 약재로 알려져 있으며, 칼륨(K) 많이 함유되어 있어 택사를 복용하게되면 뇨중의 칼륨(K)의 배출이 현저히 증가된다. 또한 택사는 혈중 콜레스테롤을 감소시키고, 혈압 및 혈중의 당을 낮추는 작용이 있고 사염화 탄소로 유발된 간독성에 유효한 보간작용이 있음이 보고된 바 있다. 또한 최근에는 택사분말이 무좀에 도포약으로 쓰이고 있어 택사에는 다양한 생리활성물질이 존재하는 것으로 생각된다. 그러나 택사의 생리활성에 대한 실제적인 연구결과는 매우 부족하며 이를 이용한 건강식품에 대한 개발도 미흡한 실정이다. Alismatis Rhizoma , an Alismataceae plant, is a remnant group differentiated during the evolution of monocotyledonous plants, with about 13 genera and 90 species distributed worldwide. Fujian, Jiangxi, Sichuan, Guitian and It is also produced in Yunnan province, and in Korea, it is produced in the Jeonnam Suncheon region, which accounts for more than 50% of its production, in Muan, Gurye, and Sangju, Gyeongsangbuk-do, and the taxa used as a herbal medicine is Alisma plantago- aquatica L. var. orientale Samuels) is mainly grown and produced. The constituents of taxa are known as 25% starch, 7% protein, furfural, resin, essential salts, alisol A, B, C, and acetates and acetates of triterpenoids. Such taxa is known as a medicine that removes moisture, helps the intestine, and strengthens energy. It is contained a lot of potassium (K), and when the taxi is taken, potassium (K) in the urine is significantly increased. Taxa has also been reported to reduce blood cholesterol, lower blood pressure and blood sugar, and have an effective interpolation effect on hepatotoxicity induced by carbon tetrachloride. In addition, recently, the tack powder is used as a coating agent for athlete's foot athletes, it is thought that a variety of physiologically active substances present in the tack. However, the actual research results on physiological activity of taxis are very insufficient and the development of health foods using them is insufficient.

본 발명자들은 상기와 같은 점을 착안하여 순천지역에서 생산되는 택사의 항균, 항산화 활성 및 면역반응 조절작용에 미치는 영향 등과 같은 생리활성을 규명하고 택사를 발효주로 제조함으로써 본 발명을 완성하였다.The present inventors have completed the present invention by identifying the physiological activity such as the effect on the antibacterial, antioxidant activity and immune response control action of the taxi cab produced in Suncheon area by focusing on the above points.

따라서, 본 발명의 목적은 택사발효주를 제공하는 것이다. 본 발명의 다른목적은 택사발효주의 제조방법을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a fermented liquor. Another object of the present invention is to provide a method for preparing a taxin fermented wine.

도 1은 본 발명의 바람직한 제조방법의 실시예를 공정별로 도시한 개략도이다.1 is a schematic diagram showing an embodiment of a preferred manufacturing method of the present invention for each process.

도 2은 본 발명 택사추출물의 항균활성 측정을위해 시험균주에 택사 물추출물을 첨가한후 생성된 생육저해환을 나타내는 평판배지의 사진도이다.Figure 2 is a photograph of a plate medium showing the growth inhibition ring produced after the addition of the tax water extract to the test strain to determine the antimicrobial activity of the tax extract of the present invention.

도 3a는 본 발명 택사추출물의 바실러스 서브틸러스(B. subtilis)균주의 성장 억제효과를 나타낸 그래프이다.Figure 3a is a graph showing the growth inhibitory effect of the Bacillus subtilis strain of the present invention tack extract.

도 3b는 본 발명 택사추출물의 슈도모나스 아에리그노사(Pseudomonas aerignosa) 균주의 성장 억제효과를 나타낸 그래프이다.Figure 3b is a graph showing the growth inhibitory effect of Pseudomonas aerignosa strain of the present taxa extract.

도 3c는 본 발명 택사추출물의 대장균(E.coli) 균주의 성장 억제효과를 나타낸 그래프이다.Figure 3c is a graph showing the growth inhibitory effect of E. coli strains of the present invention tack extract.

도 3d는 본 발명 택사추출물의 살모넬라 티피무리움(Salmonella typhymuriu- Figure 3d is Salmonella typhymuriu of the present invention taxa extract ( Salmonella typhymuriu-

m)균주의 성장 억제 효과를 나타낸 그래프이다. m ) It is a graph showing the growth inhibitory effect of the strain.

도 3e는 본 발명 택사추출물의 비브리오 파라하모리티커스(Vibrio parahaemo liticus) 균주의 성장 억제효과를 나타낸 그래프이다.Figure 3e is a graph showing the growth inhibitory effect of the Vibrio parahaemo liticus strain of the present taxa extract.

도 4은 택사추출물 처리에 따른 살모넬라 티피무리움(Salmonella typhymuriu Figure 4 is Salmonella typhymuriu according to the process of extracting the taxa ( Salmonella typhymuriu

m)의 전자현미경 사진도이다. m ) electron micrograph.

도 5는 50℃에서 7일 동안 리놀레산 자동산화 과정중 택사추출물(100㎕) 첨가에 따른 과산화물가의 변화를 나타낸 그래프이다.Figure 5 is a graph showing the change in peroxide value according to the addition of the tack extract (100 μl) during linoleic acid automatic oxidation for 7 days at 50 ℃.

도 6는 50℃에서 7일 동안 리놀레산의 자동산화 과정중 택사추출물을 농도별 첨가에 따른 과산화물가의 변화를 나타낸 그래프이다.Figure 6 is a graph showing the change in peroxide value according to the concentration of the tax extract during the automatic oxidation of linoleic acid for 7 days at 50 ℃.

도 7은 본 발명 택사추출물을 쥐간에 처리시 TBA가의 변화를 나타낸 그래프이다.Figure 7 is a graph showing the change in TBA value when the present invention is treated with a rat extract.

도 8a는 본 발명 택사추출물을 비장세포에 처리시 비장세포의 증식에 미치는 영향을 나타낸 그래프이다.Figure 8a is a graph showing the effect on the proliferation of splenocytes when the present invention is treated to splenocytes.

도 8b는 본 발명 택사추출물을 B세포에 처리시 B세포의 증식에 미치는 영향을 나타낸 그래프이다.Figure 8b is a graph showing the effect on the proliferation of B cells when the present invention is treated to B cell tack extract.

도 9a는 본 발명 택사추출물이 동종항원에 대해 반응하는 T세포 증식에 미치는 영향을 나타낸 그래프이다.Figure 9a is a graph showing the effect of the present invention tack extract on T cell proliferation in response to homologous antigen.

도 9b는 본 발명 택사추출물이 동종항원에 대해 반응하는 T세포의 저해도를 나타낸 그래프이다.Figure 9b is a graph showing the degree of inhibition of T cells in response to the tax extract of the present invention homologous antigen.

도 10는 본 발명 택사추출물이 동종항원에 대해 반응하는 T세포의 세포독성에 미치는 영향을 나타낸 그래프이다.Figure 10 is a graph showing the effect of the present invention taxa extract on the cytotoxicity of T cells in response to homologous antigen.

도 11은 본 발명에 의한 택사발효주 제품의 사진도이다.Figure 11 is a photographic representation of the fermentation liquor product of the present invention.

도 12는 본 발명 택사발효주의 2차 발효기간 중 알콜함량 변화를 나타낸 그래프이다.12 is a graph showing the alcohol content change during the second fermentation period of the present invention fermentation taxa.

도 13은 본 발명 택사발효주의 2차 발효기간 중 이산화탄소(CO2) 발생량의 변화를 나타낸 그래프이다.Figure 13 is a graph showing the change in the amount of carbon dioxide (CO 2 ) generated during the secondary fermentation period of the present invention fermentation taxa.

도 14는 본 발명 택사발효주의 2차 발효기간 중 총산 함량의 변화를 나타낸 그래프이다.Figure 14 is a graph showing the change in total acid content during the secondary fermentation period of the present invention fermentation taxa.

도 15는 본 발명 택사발효주의 2차 발효기간 중 환원당 함량의 변화를 나타낸 그래프이다.15 is a graph showing a change in the reducing sugar content during the second fermentation period of the present invention fermentation taxa.

도 16은 본 발명 택사발효주의 2차 발효기간 중 유리당 함량의 변화를 나타낸 그래프이다.Figure 16 is a graph showing the change in free sugar content during the secondary fermentation period of the present invention fermentation taxa.

도 17은 본 발명 택사발효주의 관능평가결과를 나타낸 그래프이다.17 is a graph showing the sensory evaluation results of the present invention fermentation strain.

본 발명의 상기 목적은 택사 추출물을 제조하여 식중독 및 병원성 미생물에 대한 항균활성, 리놀레산과 간지질에 대한 항산화 효과 및 면역활성을 확인한 뒤 흑국균(Aspergillus awamori)을 증자한 쌀에 접종하고 배양하여 코지(Koji)를 제조하고, 상기 코지에 급수하고 효모(Saccharomyces cereviceae)를 접종한 다음 48시간 발효하여 주모를 제조하고 증자한 택사에 상기 주모를 접종하여 6일간 발효한후 여과하고 제균하여 택사발효주를 제조하고 설탕을 여러 농도로 첨가하여 기호도를 관능평가요원 20명을 대상으로 각각 조사하여 비교함으로써 달성하였다.The object of the present invention is to prepare a taekta extract to check the antimicrobial activity against food poisoning and pathogenic microorganisms, the antioxidant effect and immune activity against linoleic acid and liver lipids, and then inoculated and cultured in rice cooked with Aspergillus awamori koji koji Koji was prepared, watered to the koji and inoculated with yeast ( Saccharomyces cereviceae ) and fermented for 48 hours to prepare a hair seedling . Prepared and added sugar in various concentrations to achieve the palatability of 20 sensory evaluation personnel by comparing and respectively.

이하, 본 발명의 구성을 설명한다.Hereinafter, the configuration of the present invention will be described.

본 발명은 택사의 항균, 항산화 및 면역활성을 조사하기 위하여 메탄올, 에탄올 및 물을 사용하여 택사 추출물을 제조하는 단계; 상기 택사추출물의 항균 활성을 조사하기 위하여 식중독 및 병원성 미생물에 대한 항균활성을 측정하고, 택사추출물의 처리에 따른 미생물의 형태변화를 조사하는 단계; 택사추출물의 항산화효과를 조사하기 위하여 리놀레산에 대한in vitro항산화 효과 및 간 지질과산화 억제 기능에 대하여 조사하는 단계; 택사 추출물의 면역세포 증식효과, 대식세포주의 일산화질소 생산에 미치는 영향, 동종항원에 대한 증식반응, 동종항원에 의한 T세포 사이토카인 분비량의 억제 및 동종항원에 대한 T세포의 살세포 작용 억제효과를 조사하는 단계; 쌀을 2시간정도 불린후에 절수하고 증자한 뒤 흑국균(Aspergillus awamori)를 접종하여 45℃에서 48시간 배양함으로써 코지(koji)를 제조하는 단계;상기 단계의 흑국균에 물과 효모(Saccharomyces cereviceae)를 접종하여 48시간 1차 발효하여 주모를 제조하는 단계; 택사를 2시간 불린 후 절수하고 증자한 다음 상기 단계의 1차 발효물과 물을 넣고 30℃에서 6일간 발효한 뒤 여과하고 제균하여 제품화하는 단계; 본 발명 택사발효주의 2차 발효 기간중 알콜 함량의 변화를 조사하는 단계; 본 발명 택사발효주의 2차 발효 기간중 이산화탄소 발생량의 변화를 조사하는 단계; 본 발명 택사발효주의 2차 발효 기간중 총산 함량의 변화를 조사하는 단계; 본 발명 택사발효주의 2차 발효 기간중 환원당과 유리당 함량의 변화를 조사하는 단계; 본 발명 택사발효주의 유기산 함량을 조사하는 단계; 본 발명 택사발효주의 무기성분 함량을 조사하는 단계; 본 발명 택사발효주의 유리아미노산 함량을 조사하는 단계; 설탕을 0, 2, 5% 첨가한 본 발명 택사발효주를 5점법에 의한 관능평가하여 기호도를 비교하는 단계로 구성된다.The present invention comprises the steps of preparing a taxi extract using methanol, ethanol and water to investigate the antibacterial, antioxidant and immune activity of the taxi; Measuring antimicrobial activity against food poisoning and pathogenic microorganisms to investigate the antimicrobial activity of the taxa extract, and examining the morphological changes of the microorganisms according to the treatment of the taxa extract; Irradiating with respect to the in vitro antioxidant activity and lipid peroxidation inhibiting liver functions for the linoleic acid in order to examine the antioxidant activity of the extract Alismataceae; Effects of Taxa Extract on Immune Cell Proliferation, Effects of Macrophage Cells on Nitric Oxide Production, Proliferative Response to Homologous Antigens, Inhibition of T Cell Cytokine Secretion by Homologous Antigens, and T Cell Killer Action on Homologous Antigens Investigating; After soaking rice for about 2 hours and then watering and increasing, inoculate with black rice (Aspergillus awamori) to incubate for 48 hours at 45 ℃ to prepare a koji (water) and yeast (Saccharomyces cereviceae) Inoculating the primary fermentation for 48 hours to prepare a hair seed; 2 hours after the taxi was called, water saving and steaming were added, and the first fermented product and water were added thereto, followed by fermentation at 30 ° C. for 6 days, followed by filtration and sterilization to produce products; Investigating the change of alcohol content during the second fermentation period of the present invention fermentation taxa; Investigating the change in the amount of carbon dioxide generated during the second fermentation period of the taxi fermentation strain of the present invention; Investigating the change of the total acid content during the second fermentation period of the taxi fermentation strain of the present invention; Investigating the change of the reducing sugar and free sugar content during the second fermentation period of the taxi fermentation strain of the present invention; Investigating the organic acid content of the present invention fermentation taxa; Investigating the inorganic component content of the present invention fermentation taxa; Investigating the free amino acid content of the present invention fermentation taxa; It consists of a step of comparing the preference degree by sensory evaluation by the five-point method of the present invention fermented liquor with 0, 2, 5% of sugar.

본 발명 택사(Alismatis Rhizoma)는 1998년 전남 순천에서 수확한 것을 구입하여 사용하였다. 항균활성, 항산화능 및 면역활성을 측정하기 위하여 사용한 택사(Alismatis Rhizoma) 추출물은 메탄올, 에탄올 및 물과 같은 용매를 사용하여 택사 100g당 1500ml의 비율로 용매를 첨가하고 환류냉각기를 이용하여 메탄올과 에탄올은 80℃, 물은 100℃에서 2시간 추출한후 택사 g 당 0.5ml가 되도록 농축하여 제조하였다. Alismatis Rhizoma of the present invention purchased and used harvested in Suncheon, Jeonnam in 1998. Alismatis Rhizoma extract used to measure antimicrobial, antioxidant and immune activity was added at a rate of 1500 ml per 100 g of taxa using solvents such as methanol, ethanol and water, and methanol and ethanol using a reflux cooler. Silver 80 ℃, water was prepared by extracting at 100 ℃ 2 hours and concentrated to 0.5ml per g of taxi.

항균 시험용으로 사용한 균주Bacillus subtilis,Pseudomonas aeruginosa,Escherichia coli,Salmonella typhimurium,Escherichia coliO-157 및Vibrio parahaemolyticus는 한국 종균협회에서 분양 받아 사용하였다. 각종 미생물의 배양에 사용된 배지는 영양 배지(nutrient broth, agar)를 사용하였으며,Vibrio parahaemoliticus는 3% NaCl이 첨가된 배지를 사용하였다.The strains Bacillus subtilis , Pseudomonas aeruginosa , Escherichia coli , Salmonella typhimurium , Escherichia coli O-157 and Vibrio parahaemolyticus were used for antimicrobial testing. Nutrient broth (agar) was used for the culture of various microorganisms, and 3% NaCl was added for Vibrio parahaemoliticus .

택사의 면역활성 측정을 조사하기 위해 사용한 생쥐(BALB/c, C57BL/6)는, 대한실험동물센터(충북 음성군)에서 구입한 후 생후 8∼12주된 암컷을 사용하였으며, 실험 전까지 고형사료와 1차 증류수를 공급하면서 사육하였다. RPMI 1640배지, 안티바이오틱 안티마이코틱은 Gibco BRL(Grand Island, NY, USA)제품을 사용하였으며, FCS(fertal calf serum)은 PAA제품을 사용하였다. LPS와 2-ME(2-mercaptoehtanMice (BALB / c, C57BL / 6) used to investigate the immune activity of taxa were purchased from the Korea Experimental Animal Center (negative group Chungbuk), and 8-12 weeks old females were used. It was bred while supplying tea distilled water. RPMI 1640 medium, antibiotic antimicrobial was used Gibco BRL (Grand Island, NY, USA) products, FCS (fertal calf serum) was used PAA products. LPS and 2-ME (2-mercaptoehtan

ol), NaHCO3, N-1-나프틸-에틸렌-디아민(N-1-naphthyl-ethylen-diamine)과 썰파닐아마이드(Sufanilamide)는 Sigma사 제품을 사용하였다. 또한 세포독성 측정(Cytotoxicity assay)에 사용된 시약(Cyto Tox 96Non-radioactive Cytotoxicity Assay)과 세포증식 측정에 사용된 시약(Cell titer96Aqueous One solution cell proliferation Assay)은 Promega사 제품을 사용하였고, 사이토카인(cytokine)측정에 필요한 항체는 Pharmingen사의 제품을 사용하였다. B 세포 분리에 사용된 Sephadex G-10도 Pharmingen사의 제품을 사용하였다. 세포배양을 위한 세포주로는 생쥐 단핵/대식세포 계열의 세포주인 RAW264.7을 한국세포주은행(서울대학교 의과대학 암연구소)에서 구입하였다. 상기 세포배양을 위한 배지는 RPMI 1640배지에 NaHCO32g/L와 페니실린(penicillin) 100unit/ml, 스트렙토마이신 100mg/ml를 첨가하여 사용하였다.ol), NaHCO 3, N-1-naphthyl-ethylen-diamine and sulfanamide were used by Sigma. In addition, the reagents used in the cytotoxicity assay (Cyto Tox 96). Non-radioactive Cytotoxicity Assay and Reagents Used to Measure Cell Proliferation (Cell titer96) Aqueous One Solution Cell Proliferation Assay was used for Promega, and the antibodies required for cytokine measurement were used for Pharmingen. Sephadex G-10 used for B cell separation was also used by Pharmingen. As a cell line for cell culture, RAW264.7, a mouse mononuclear / macrophage cell line, was purchased from Korea Cell Line Bank (Seoul National University College of Medicine). Medium for the cell culture was used by adding NaHCO 3 2g / L, penicillin 100unit / ml, streptomycin 100mg / ml to RPMI 1640 medium.

본 발명 택사발효주의 알콜함량은 8∼10%이며 바람직하게는 9%이다. 또한 택사발효주의 쓴맛을 감소시키기 위해 첨가하는 설탕의 농도는 2∼7%이며 바람직하게는 5%이다.The alcohol content of the present invention fermented liquor is 8 to 10%, preferably 9%. In addition, the concentration of sugar added to reduce the bitter taste of the taxi fermentation liquor is 2 to 7%, preferably 5%.

본 발명 택사발효주의 환원당과 유리당의 측정에 사용한 HPLC는 00사(제조회사명, 모델명을 기입해주세요)의 것이였으며 무기성분 분석에 사용한 ICP는 00사(제조회사명, 모델명을 기입해주세요)의 것을 사용하였다. 본 발명 택사발효주의 유리아미노산 측정에 사용한 아미노산 자동분석기는 00사(제조회사명, 모델명을 기입해주세요)의 것을 사용하였다.The HPLC used for the measurement of reducing sugars and free sugars of the present invention fermentation liquor was from 00 company (please fill in the manufacturer's name and model name), and the ICP used for inorganic component analysis was from 00 company (please fill in the manufacturer's name and model name). Used. The amino acid automatic analyzer used for free amino acid measurement of taxa fermentation strain of the present invention was used by 00 company (please fill in manufacturer name and model name).

본 발명 택사발효주의 바람직한 제조방법은 도 1에 도시하였다Preferred manufacturing method of the present invention fermented liquor is shown in FIG.

이하, 본 발명의 구체적인 방법을 실시예를 들어 상세히 설명하고자 하지만,본 발명의 권리범위는 이들 실시예에만 한정되는 것은 아니다.Hereinafter, the specific method of the present invention will be described in detail with reference to Examples, but the scope of the present invention is not limited only to these Examples.

실험예 1: 택사 추출물의 항균효과 조사Experimental Example 1: Investigation of antimicrobial effect of taxa extract

택사 추출물의 항균효과를 조사하기 위하여 택사 추출물을 사용하여 항균력, 미생물 생육도에 미치는 영향, 미생물의 형태변화에 미치는 영향을 조사하였다.In order to investigate the antimicrobial effect of taxa extracts, the effects of antimicrobial activity, microbial growth, and microbial morphology were investigated.

항균력의 측정은 Farag의 방법을 변형하였다. 즉, agar 1.5%가 함유되어 있는 생육배지를 페트리 디쉬(petri dish)의 밑면에 얇게 펴고 그위에 다시 0.6%의 agar가 함유된 생육배지를 부어 2중의 평판 배지를 만든 후 각 균주를 평판배지에 도말하였다. 상기 균주가 도말된 평판배지에 택사추출물을 일정량 가한 직경 0.8cm의 여지 디스크(disc)를 올려놓고 36℃에서 24시간 배양한 뒤, 생성되는 생육저해환을 측정하여 항균력을 조사하였다.The measurement of antimicrobial activity modified Farag's method. That is, the growth medium containing 1.5% of agar is thinly spread on the bottom of a petri dish, and the growth medium containing 0.6% of agar is poured on it to make a double flat medium, and then each strain is placed on the flat medium. Smeared. The strain was placed on a plate medium coated with a certain amount of the tackifier extract 0.8cm in diameter filter disk (disc) and incubated for 24 hours at 36 ℃, the resulting growth inhibition was measured to investigate the antibacterial activity.

미생물의 생육도 측정은 액체배지 희석법을 사용하였다. 시험관에 5ml의 생육배지를 넣고 대수기 중기까지 배양된 균체 배양액 1%를 접종한 후 택사 추출물 함량을 배지 5ml당 30∼200㎕가 되도록 첨가하고 각 균주의 최적 온도에서 배양하면서 경시적으로 미생물의 생육정도를 분광광도계(spectrophotometer)를 사용하여 660nm에서 흡광도를 측정하였다.Microbial growth was measured using the liquid medium dilution method. Inoculate 5 ml of growth medium into the test tube and inoculate 1% of the cell culture cultured up to the middle of the logarithmic season, and then add tac extract extract to 30 to 200 µl per 5 ml of medium and incubate at optimum temperature of each strain. The extent of growth was measured by absorbance at 660nm using a spectrophotometer.

택사(Alismatis Rhizoma) 추출물에 의한 미생물의 형태변화 조사는 식품부패 미생물에 택사 추출물을 처리한 후 전자현미경으로 그 형태 변화를 관찰하였다. 부패미생물로Salmonella typhimurium을 배지에 48시간 배양한 다음 배양 균주 일부에 택사 추출물을 배지 ml당 100㎕로 첨가하고 3시간 방치한 뒤 이를 원심분리하여 균체를 분리한 후 0.05M 인산 완충액(phosphate buffer)으로 희석하고 0.45㎕ 멤브레인 필터(membrane filter)에 균체를 고정하였다. 이를 5% 글루타알데하이드(glutaaldehyde) 용액에 하룻밤 담구어 멸균수로 세척한 뒤 30∼100%의 에탄올에 차례로 담구어 탈수하고, 이소아밀아세테이트(isoamylacetate)에 약 30분간 담구어 건조시킨 후 전자현미경 촬영시료를 조제하여 관찰하였다.The morphological changes of microorganisms by Alixmatis Rhizoma extracts were treated with food extract microorganisms and their morphological changes were observed by electron microscopy. Incubate Salmonella typhimurium as a decay microorganism in a culture medium for 48 hours, add 100 microliters of taxa extract per ml of culture strain to the culture strain, leave for 3 hours, and centrifuge to isolate the cells. 0.05M phosphate buffer The cells were diluted with and fixed to 0.45 μl membrane filter. Soak overnight in 5% glutaaldehyde (glutaaldehyde) solution, wash with sterile water, and then immerse in 30 ~ 100% ethanol one by one in order to dehydrate, immerse in isoamylacetate for about 30 minutes to dry and electron microscope The photographing sample was prepared and observed.

실험 결과, 택사 추출물의 항균 활성은 도 2와 표1에 나타낸 바와 같이, 물추출물이 메탄올 및 에탄올 추출물보다 항균활성이 강하게 나타났다. 또한Escherichia coliO-157균주를 제외한 모든 시험균주에 대하여 항균활성이 강하게 나타났으며 각 시험균주에 대한 택사 추출물의 투명환(clear zone)은Vibrio parahaemolyticus, Bacillus subtilis, Salmonella typhimurium, Pseudomonasaeruginosa 및 Escherichia coli에 대하여 각각 18.0, 16.0, 16.0, 13.0, 11.5mm였으며 특히,Vibrio parahaemolyticus균주에 대해서 항균활성이 가장 강하게 나타났다.Experimental results, as shown in Figure 2 and Table 1, the antimicrobial activity of the taxa extract, water extract showed stronger antimicrobial activity than methanol and ethanol extract. Also had antimicrobial activity appeared strongly to all tested strains except for Escherichia coli O-157 strain clear zone (clear zone) of Alismataceae extract of each test strain in Vibrio parahaemolyticus, Bacillus subtilis, Salmonella typhimurium, Pseudomonasaeruginosa and Escherichia coli 18.0, 16.0, 16.0, 13.0, and 11.5mm, respectively, and the antimicrobial activity of Vibrio parahaemolyticus was the strongest.

택사 추출물의 항균활성Antimicrobial Activity of Taxa Extracts 균주Strain 메탄올 추출물Methanol extract 에탄올 추출물Ethanol extract 물 추출물Water extract Bacillus subtilisBacillus subtilis 14.014.0 13.513.5 16.016.0 Pseudomonas aerignosaPseudomonas aerignosa 14.014.0 14.014.0 13.013.0 E.coliE.coli 11.011.0 11.011.0 11.511.5 Salmonella typhymuriumSalmonella typhymurium 14.014.0 13.513.5 16.016.0 E.coliO-157 E.coli O-157 8.08.0 8.08.0 8.08.0 Vibrio parahaemolyticuaVibrio parahaemolyticua 16.016.0 16.516.5 18.018.0 〔주〕단위 :mm(Note) Unit: mm

택사(Alismatis Rhizoma) 추출물이 미생물의 증식에 미치는 영향을 조사한 결과, 도 3a∼3e에 나타낸바와 같이 택사추출물을 배지 5ml당 30㎕만 첨가하여도 균의 성장이 억제되었으며 150㎕ 첨가시는 거의 모든균에서 대조구에 비하여 50% 이상 균의 성장이 억제되었으며, 200㎕ 첨가시는 균의 성장이 거의 억제되었다.As a result of investigating the effect of Alismatis Rhizoma extract on the growth of microorganisms, as shown in Figs. 3a to 3e, the growth of the bacteria was inhibited even by adding 30 μl of the Taxa extract per 5 ml of the medium. The growth of the bacteria was inhibited by more than 50% compared to the control, and the growth of the bacteria was almost suppressed when 200μl was added.

택사 추출물 처리에 따른 미생물의 형태 변화를 조사한 결과, 도 4에 나타낸 바와 같이Salmonerlla typhimurium에 택사 물추출물을 처리한 후 대조구와 비교시 균체의 표층구조가 허물어지는 심한 형태적 변화를 나타내었다. 서 등(서권일,이상원, 양기호 :한국농산물저장유통학회(1999), 6(1))은E.coliO-157에 산수유 물추출물을 처리한 후 전자현미경으로 관찰한 결과 대조구와 비교하여 산수유 물추출물을 처리한 균체에서 세포막 기능이 파괴되어 세포내용물이 균체 외부로 유출되어균체의 생육이 억제되는 현상을 나타내었다고 보고하였고, 서 등은 대장균에 겨자 물추출물을 처리하였을 때 균체 표면이 수축되고 표층구조가 심하게 허물어졌다고 보고하였는데, 본 결과의 이와 같은 현상들도 상기의 연구보고와 비교하여 볼 때 택사 물추출물에 의한 미생물의 세포벽 및 세포막의 기능이 파괴되어 용균이나 균체성분의 노출로 인한 결과라고 생각된다.As a result of investigating the morphological changes of the microorganisms according to the extract of the taxa extract, as shown in FIG. 4, after treating the taxa water extract with Salmonerlla typhimurium , the surface structure of the cells was severely compared with the control group. Seo et al. (Seo Kwon Il, Sang Won Lee, Ki Ho Ho: Korean Agricultural Products Storage and Distribution Association (1999), 6 (1)), treated with E. coli O-157 extracts of cornus water, were observed by electron microscopy. It was reported that the cell membrane function was disrupted in the cells treated with the extract and the contents of the cells were leaked out of the cells, thereby inhibiting the growth of the cells. It was reported that the structure was severely collapsed.These phenomena are also the result of the exposure of lysates or cell components due to the destruction of the cell wall and cell membrane of microorganisms by taxi water extract. I think.

실험예 2: 택사 추출물의 항산화 효과 조사Experimental Example 2: Investigation of Antioxidant Effect of Taxa Extract

택사 추출물(Alismatis Rhizoma)의 리놀레산(linoleic acid)에 대한in vitro항산화 및 간 지질과산화 억제 기능에 대하여 조사하였다. 택사 추출물의 항산화 효과 측정을 위하여 삼각플라스크에 리놀레산(linoleic acid) 1g, 에탄올(ethanol) 10ml 및 소정의 택사 추출물을 첨가한 후 0.2M 인산완충용액(phosphate buffer) 25ml를 가하여 37℃에서 일정기간 저장한 다음 반응용액을 분액깔대기에 옮겨 클로로포름(chloroform) 25ml를 가하여 2∼3회 반복 추출하였다. 상기 클로로포름(chloroform) 추출액에 아세트산(acetic acid) 25ml와 포화 KI용액 1ml를 가하여 암소에서 5분간 방치한 다음 증류수 50ml를 가하여 1/100 N Na2S2O3용액으로 적정하였다. 택사추출물은 각각 메탄올, 에탄올, 물추출물을 첨가하였고, BHT 0.1%를 첨가하여 50℃에서 7일간 저장하면서 과산화물가를 측정하였다.The in vitro antioxidant and hepatic lipid peroxidation inhibitory effects on linoleic acid of Alismatis Rhizoma were investigated. In order to measure the antioxidant effect of taxa extract, 1 g of linoleic acid, 10 ml of ethanol, and a predetermined taxa extract were added to a Erlenmeyer flask, and 25 ml of 0.2 M phosphate buffer was added and stored at 37 ° C. for a period of time. Then, the reaction solution was transferred to a separatory funnel, and 25 ml of chloroform was added thereto, followed by extraction two to three times. 25 ml of acetic acid and 1 ml of saturated KI solution were added to the chloroform extract, which was allowed to stand in the dark for 5 minutes, and then 50 ml of distilled water was added and titrated with a 1/100 N Na 2 S 2 O 3 solution. Taxi extract was added methanol, ethanol, and water extract, respectively, and BHT 0.1% was added and stored at 50 ° C. for 7 days to measure peroxide value.

택사 추출물의 지질과산화 억제효과는 흰쥐의 간 균질액(liver homogenate)를 사용하여in vitro로 조사하였다. 흰쥐의 간을 적출하여 인산완충용액(phospha-Lipid peroxidation inhibitory effect of Taxa extract was investigated in vitro using liver homogenate in rats. Phosphate buffer solution (phospha-

te buffer, pH 7.4)로 균질화한 다음 균질액에 과산화수소(H2O2) 1M과 50mM의 황산철(FeSO4) 및 택사 추출물 0.05ml를 가하여 42℃에서 72시간 동안 저장한 후 생성된 TBARS(thiobarbituric acid reactive substances)함량을 측정하였다.After homogenization with te buffer, pH 7.4), 1M of hydrogen peroxide (H 2 O 2 ), 50 mM iron sulfate (FeSO 4 ), and 0.05 ml of taxa extract were added to the homogenate, and stored at 42 ° C. for 72 hours. thiobarbituric acid reactive substances) was measured.

실험결과, 도 5에 나타낸 바와 같이 택사 메탄올 추출물, 에탄올 추출물 및 물추출물 100㎕ 첨가시 대조구에 비하여 과산화가가 모두 낮게 나타났으며, 물추출물의 과산화물가는 메탄올 및 에탄올 추출물보다 작았으나, 0.1% BHT 첨가시 보다는 조금 높게 나타났다. 또한 택사 물추출물을 50, 100, 150 및 200㎕의 농도로 첨가한 후 과산화물가를 측정한 결과, 도 6에 나타낸 바와 같이 모두 대조구에 비하여 매우 낮게 나타났으며, 150㎕ 첨가시는 5일 저장시까지 과산화물이 거의 생성되지 않았는데 이는 0.1% BHT 100㎕를 첨가한 경우와 비슷한 정도의 효과였다. 권 등(권오근, 손진창, 김상철, 정신교, 박승우 :한국농산물저장유통학회(1998), 5(281))은 목단피 메탄올 추출물의 에칠아세테이트 분획의 리놀레산(linoleic acid)에 대한 항산화 효과가 87.3%이었고, 비교구인 BHT는 96.2%로 나타났다고 보고하였고, 서 등(서권일, 이상원, 양기호 :한국농산물저장유통학회(1999), 6(1))은 리놀레산(linoleic acid)에 대하여 산수유 물추출물을 10, 30 및 50㎕ 첨가하고 50℃에서 7일간 저장한 후 과산화물가를 측정한 결과 대조구의 187meq/kg에 비하여 42, 30 및 25meq/kg으로 나타나 상당한 항산화 효과가 있는 것으로 보고하였는데, 본 실험결과 택사 물추출물을 50㎕만 첨가하여도 상당한 항산화 효과가 있는 것으로 나타났다.As a result, as shown in FIG. 5, when the methanol extract, ethanol extract, and water extract 100 μl were added, the peroxide value was lower than that of the control, and the peroxide value of the water extract was smaller than that of the methanol and ethanol extracts, but was 0.1% BHT. A little higher than when added. In addition, as a result of measuring the peroxide value after adding the water extracts of the taxi water at the concentrations of 50, 100, 150 and 200 μl, as shown in FIG. 6, all of them appeared to be very low compared to the control, and when 150 μl was added, it was stored until 5 days. Almost no peroxide was produced, which was about the same as adding 100 μl of 0.1% BHT. Kwon et al. (Kwon Oh-Geun, Son Jin-Chang, Sang-Chul Kim, Sang-Cheol Kim, Pyo-Sang, Park, Seung-Woo: Korean Society of Agricultural Products and Storage (1998), 5 (281)) showed that the antioxidant activity of linoleic acid in the ethyl acetate fraction of methanol extract was The comparison group reported that BHT was 96.2%, and Seo et al. (Seo, Kwon-Il, Sang-Won Lee, and Ki-Ho Yang: Korean Agricultural Products Storage and Distribution Association (1999), 6 (1)) showed that the extracts of linusic acid were 10, 30 and After adding 50 μl and storing at 50 ° C. for 7 days, the peroxide value was measured to be 42, 30 and 25 meq / kg compared to 187 meq / kg of the control, which showed a significant antioxidant effect. Addition of only μl showed significant antioxidant effect.

흰쥐의 간 지질에 대한 TBA가는 도 7에 나타낸 바와같이 택사 물추출물울 첨가하지 않은 대조구에서 3597μmol malondialdehyde(MDA)/g liver이었고, 택사 물추출물을 첨가한 시험구들의 TBA가는 1443 μmol MDA/g liver로서 모두 대조구에 비하여 낮게 나타나 항산화 효과가 있었다.The TBA value of liver lipids in rats was 3597 μmol malondialdehyde (MDA) / g liver in the control group without the addition of tax water extract as shown in FIG. 7, and the TBA value of the test groups to which the water extract was added was 1443 μmol MDA / g liver. All showed lower anti-oxidant effect than the control.

실험예 3: 택사 추출물의 면역활성 측정Experimental Example 3: Determination of Immune Activity of Taxa Extract

택사(Alismatis Rhizoma) 추출물의 면역세포 증식효과, 대식세포주의 일산화질소 생산에 미치는 영향, 동종항원에 대한 증식반응, 동종항원에 의한 T세포 사이토카인(cytokine) 분비량의 억제, 동종항원에 대한 T세포의 살세포 작용 억제효과 등을 조사하였다. 생쥐의 비장세포 분리를 위하여 생쥐(BALB/c)를 경추탈골로 희생시킨 후, 알콜로 소독하여 해부대에 올려놓고 오른쪽 옆구리쪽을 절개하여 비장을 떼어 내었다. 상기 비장을 핀셋을 이용하여 단일세포(single cell)로 만들고 세척용 배지로 3회 세척후 적당량의 10% FCS-RPMI 1640 배지에 희석하여 사용한다. 상기 분리된 비장세포를 10ml의 10% FCS-RPMI 1640에 희석한 후 40㎕ anti-Thy1.2 ascites를 넣고 4℃에서 60분간 배양하였다. 그 후에 4℃, 1200rpm에서 6분간 원심침전하여 5ml의 FCS-RPMI 1640에 희석하고 250㎕ rabbit complement를 첨가하여 37℃ 수욕에서 45분간 배양하였다. 그 다음 10ml 세척용 배지로 4℃, 1200 rpm에서 6분간 원심침전을 두 번 반복하고 10% FCS-RPMI 1640 배지 500㎕에 희석하여 세파독스 G-10(Sephadox G-10) 컬럼을 통과시켜서 B세포만을 순수분리 하였다. T세포의분리는 상기 분리된 비장세포를 10% FCS-RPMI 1640 1ml에 희석하여 Nylon wool 컬럼에 넣고 37℃, 5% CO2 배양기에 60분간 배양하였다. 배양후 나일론 울(Nylon wool) 컬럼을 37℃로 미리 데워진 배지로 세척하여 비부착성인 T세포만을 순수 분리하여 alloreative T세포로 사용하였다.Effects of Alismatis Rhizoma Extract on the Proliferation of Immune Cells, Effects of Macrophage Cells on Nitric Oxide Production, Proliferative Response to Homologous Antigens, Inhibition of T Cell Cytokine Secretion by Homologous Antigens, and T Cells Against Homogenous Antigens The inhibitory effect of killer cells was investigated. To separate the splenocytes of the mice, the mice (BALB / c) were sacrificed with cervical distal bone, sterilized with alcohol, placed on the dissection, and the spleen was removed by dissecting the right flank. The spleen is made into single cells using tweezers, washed three times with washing medium, and diluted in an appropriate amount of 10% FCS-RPMI 1640 medium. The isolated splenocytes were diluted in 10 ml of 10% FCS-RPMI 1640, and 40 µl anti-Thy1.2 ascites were added thereto and incubated at 4 ° C. for 60 minutes. Thereafter, the mixture was centrifuged at 4 ° C and 1200rpm for 6 minutes, diluted in 5ml of FCS-RPMI 1640, and incubated for 45 minutes in a 37 ° C water bath by adding 250µl rabbit complement. Then, centrifugation was repeated twice for 6 minutes at 4 ° C. and 1200 rpm with 10 ml washing medium, diluted in 500 μl of 10% FCS-RPMI 1640 medium, and passed through a Sephadox G-10 column. Only cells were purified. Separation of T cells was diluted in 1 ml of 10% FCS-RPMI 1640 and the splenocytes were separated into nylon wool column and incubated for 60 minutes in 37 ℃, 5% CO2 incubator. After incubation, the nylon wool column was washed with media preheated to 37 ° C., and only non-adherent T cells were purified and used as alloreative T cells.

비장세포, 순수 분리한 B세포, 또는 순수 분리한 T세포에 allogenic 비장세포(C57BL/6)을 96 well plate에 넣고 여기에 택사 추출물을 1, 10, 100, 1000㎍/ml농도로 넣어 배양한 다음 2일, 3일 4일째에 각 세포의 증식정도를 측정하였다. 측정은 Cell titer96Aqueous One Solution Cell proliferation Assay(promega)를 사용하여 2일, 3일, 4일째 각각 배양된 배양액 100㎕에 세포역가측정용 시약(Cell titer) 15㎕씩 첨가하고 4∼8시간 동안 배양한 다음 490nm에서 O.D값을 측정하였다.Splenocytes, purely isolated B cells, or purely isolated T cells were cultured in 96 well plates with allogenic splenocytes (C57BL / 6) in 1, 10, 100, 1000 ㎍ / ml concentrations. Next, the proliferation of each cell was measured on day 2 and day 3 and day 4. Measure the cell titer96 15 μl of cell titer was added to 100 μl of the culture solution on day 2, 3, and 4 using Aqueous One Solution Cell proliferation Assay (promega), followed by incubation for 4 to 8 hours, followed by 490 nm. OD value was measured at.

택사 추출물이 대식세포주의 일산화질소 생산에 미치는 효과를 알아보기 위하여 택사 추출물을 1, 10, 100, 1000㎍/㎖의 농도로 단독 처리하거나 또는 LPS, IFN-γ를 같이 첨가하였을 때, 대식세포가 생산하는 일산화질소의 농도를 측정하였다. 안정된 일산화질소(NO) 산화물인 NO2 -(nitrite)는 Griess 반응을 이용하여 측정하였다. 대식세포주(RAW264.7)를 적당한 조건하에서 48시간 배양한 후 배양 상층액을 96well plate에 100㎕씩 넣고 여기에 Greiss시약 (0.1%N-1-naphthyl-ethylendiamine in H2O + 1% sulfanilamide in 5% H3PO4)을 동량 첨가하여 10분간 반응시킨 후, 마이크로플래이트 리더(microplate reader, TitertekMultiscan Plus,Finland)로 570nm에서 흡광도를 측정하였다. 질산염(Nitrate)의 농도는 질산 나트륨(sodium nitrite)을 32μM에서부터 0.25μM까지 2배씩 희석하여 얻은 표준 곡선과 비교하여 계산하였다.To investigate the effects of taxa extract on nitric oxide production in macrophages, macrophages were treated with 1, 10, 100, and 1000 µg / ml concentrations, or when LPS and IFN-γ were added. The concentration of nitric oxide produced was measured. Stable nitrogen monoxide (NO) oxide, NO 2 - (nitrite) was measured using the Griess reaction. Incubate the macrophage line (RAW264.7) under appropriate conditions for 48 hours, add 100 µl of the culture supernatant to a 96well plate, and add Greiss reagent (0.1% N -naphthyl-ethylendiamine in H 2 O + 1% sulfanilamide in 5% H 3 PO 4 ) was added in the same amount and reacted for 10 minutes, and then the absorbance was measured at 570 nm with a microplate reader (Titertek Multiscan Plus, Finland). The concentration of nitrate was calculated by comparison with a standard curve obtained by diluting sodium nitrite from 32 μM to 0.25 μM in 2-fold.

택사 추출물이 동종항원에 의한 증식반응에 어떠한 효과를 나타내는지 알아보기 위하여, 동종항원을 유도하기 위한 세포수 결정실험을 수행하였다. 표적세포(Target cells)인 MMC를 처리한 생쥐 C57BL/6의 비장세포와 효과세포(Effector cells)로 비장세포에서 분리한 T세포(생쥐 BABL/c의 T세포)를 함께 3일동안 배양하여 최대 증식반응을 나타내는 조건을 확인하였다.In order to investigate the effects of taxa extract on the proliferative response by homologous antigens, cell number determination experiments were performed to induce homologous antigens. Splenocytes of mouse C57BL / 6 treated with MMC, which are target cells, and T cells (T cell of mouse BABL / c), which were isolated from splenocytes with effector cells, were cultured together for 3 days. The conditions showing the proliferative response were confirmed.

동종항원에 의한 T세포의 증식반응이 택사 추출물에 의하여 유의하게 억제된 원인을 알아보기 위하여, 동종항원에 반응하는 T세포가 분비하는 사이토카인(cytokine)의 생산량을 측정하였다. T세포가 반응할 때 분비하는 사이토카인(cytokine)의 양은 비장세포와 택사를 같이 배양한 상층액을 24시간 후에 회수하여 상층액에 포함된 IL-2, IL-4, IFN-γ,IL-10의 양을 ELISA(enzyme linked immounso-In order to determine the cause of the proliferation of T cells caused by allogeneic antigens significantly inhibited by the taxa extract, the amount of cytokines produced by T cells in response to allogeneic antigens was measured. The amount of cytokines secreted when T cells reacted was recovered after 24 hours of supernatant cultured with splenocytes and taxa, and IL-2, IL-4, IFN-γ, IL- contained in the supernatant. The amount of 10 ELISA (enzyme linked immounso-

rbent assay)kit로 측정하였다. 이때 사이토카인(cytokine) 농도의 측정 한계치는 10pg/ml이었다.It was measured by an rbent assay kit. At this time, the limit of measurement of cytokine concentration was 10 pg / ml.

비장세포 분리방법을 이용하여 C57BL/c 생쥐로부터 비장세포를 분리하여 마지막에 2ml의 10% FCS-RPMI 배지에 희석하고 200㎕의 마이토마이신 C(mytomycin C) 2mg/ml를 첨가하여 37℃ 수욕(water bath)에 25분간 처리하였다. 그 다음 세척용 배지로 4℃, 1200rpm에서 6분간 원심침전을 다섯번 반복하여 세척한 다음 allogen-Splenocytes were isolated from C57BL / c mice using the splenocyte separation method, diluted in 2ml of 10% FCS-RPMI medium, and 200mg of mytomycin C was added to 2mg / ml. (water bath) was treated for 25 minutes. Then, wash repeatedly with centrifuged sedimentation for 5 minutes at 4 ℃ and 1200rpm for 5 minutes with washing medium.

ic 비장세포 또는 표적세포로 사용하였다.Used as ic splenocytes or target cells.

표적세포(Target cell, allogeneic spleen cells, 1×107, 5×106/well)와 효과세포(Effetor cell,T cells, 1×106/well)의 비율(ratio)을 10:1 또는 5:1로 하여 둥근바닥 96well plate에 최종부피가 100㎕되도록 넣고 4℃, 250g에서 5분간 원심침전 시킨 후 37℃, 5% CO2배양기에 8시간 배양하였다. 단, 배양시간이 8시간이 되기 45분전에 Target maximum과 부피보정 대조구(Volume correcting control)에는 용해완충용액(Lysis Buffer)를 10배 희석하여 첨가하여 세포의 용해도가 최대가 되도록 하였다. 배양 후 4℃, 250g에서 5분간 원심침전 시킨 다음 상층액 50㎕를 떠서 평평한 바닥의 96well plate에 옮기고 여기에 50㎕ 기질혼합 완충용액(substrate mix Buffer)를 첨가하고 실온에서 알루미늄 호일을 덮어 30분간 반응시킨 다음 50㎕ 정지용액(stop soultion)을 넣고 마이크로플래이트 리더(microplate reader)를 이용하여 490nm에서 O.D.를 측정하고 상층액내에 있는 락테이트 디하이드로게나아제(lactate dehydrogenase, LDH)의 양을 측정하여 살세포작용 정도를 나타내었다. 살세포작용 정도는 하기의 식을 이용하여 산출하였다.The ratio of target cells (allogeneic spleen cells, 1 × 10 7 , 5 × 10 6 / well) and effector cells (Effetor cell, T cells, 1 × 10 6 / well) is 10: 1 or 5 : into a final volume of 96well round bottom plate 1 so as to 100㎕ were incubated 8 hours for 4 ℃, then centrifuged 5 minutes in the precipitation 250g 37 ℃, 5% CO 2 incubator. However, 45 minutes before the incubation time was 8 hours, the target maximum and volume correcting control (Lysis Buffer) was diluted 10-fold and added to the cell solubility to the maximum. After incubation, centrifuged for 5 minutes at 250 g at 4 ° C. Then, 50 µl of the supernatant was transferred to a 96-well plate on a flat bottom, and 50 µl substrate mix buffer was added thereto, and the aluminum foil was covered at room temperature for 30 minutes. After the reaction, 50 μl stop soultion was added and the OD was measured at 490 nm using a microplate reader. The amount of lactate dehydrogenase (LDH) in the supernatant was measured. The degree of killer cell activity was shown. The degree of killer cell activity was calculated using the following equation.

% CYTOTOXICITY=% CYTOTOXICITY = Expermental-Effector Spontaneous-Target SpontaneousExpermental-Effector Spontaneous-Target Spontaneous ×100× 100 Target Maximum-Target SpontaneousTarget Maximum-Target Spontaneous

생쥐의 비장세포에 택사 추출물을 농도별로 처리하여 세포의 증식정도를 측정한 결과 도 8a에 나타낸 바와 같이 무처리 대조군에 비해 택사 추출물을 처리한 실험군의 비장세포 증식정도가 농도 의존적으로 증가함을 알 수 있었다. 비장세포에 포함되어 있는 B세포만을 분리하여 택사의 B세포증식 유도효과를 측정한 결과, 도 8b에 나타낸바와 같이 비장세포에서와 마찬가지로 농도 의존적으로 증식을 증가시켰으며 특히 1000㎍/㎕의 농도에서는 월등한 상승효과가 있음을 알 수 있었다.As a result of measuring the proliferation of cells by the concentration of taxa extract in the spleen cells of the mouse by concentration, as shown in FIG. 8a, the concentration of the splenocytes in the experimental group treated with the extract was increased in a concentration-dependent manner as shown in FIG. Could. As a result of measuring the induction of B cell proliferation of taxa by separating only B cells contained in splenocytes, as shown in FIG. 8B, proliferation was increased in a concentration-dependent manner as in splenocytes, especially at a concentration of 1000 ㎍ / μl. It was found that there was an excellent synergistic effect.

택사 추출물이 대식세포주의 일산화질소(NO) 생산에 미치는 효과를 조사한 결과, 표 2에 나타낸바와 같이 무처리 대조군과 비교해보면 택사 추출물을 농도별로 단독 처리한 실험군과 LPS를 1㎍/㎖을 같이 처리한 실험군에서는 모두 대식세포의 일산화탄소(NO) 생산이 유도되지 않았다. 그러나 1ng/㎖의 IFN-γ를 같이 처리한 실험군에서는 택사 추출물의 농도가 낮을때는 약간 감소하는 경향을 보였지만, 고농도에서 일산화질소(NO)생산이 유의있게 증가하는 것을 알 수 있었다. 즉, 택사추출물이 1000㎍/㎕같은 고농도에서는 IFN-γ에 의해 유도되는 일산화질소(NO) 생산에 상승적 작용을 하는 것을 알 수 있었다.As a result of investigating the effect of taxa extract on nitric oxide (NO) production of macrophage, as compared to the untreated control group, as shown in Table 2, the experimental group treated with taxa extract alone by concentration and LPS were treated together with LPS. None of the experimental groups induced carbon monoxide (NO) production in macrophages. However, the experimental group treated with 1ng / ml of IFN-γ showed a tendency to decrease slightly at low concentrations of the taxa extract, but it was found that the production of nitric oxide (NO) was significantly increased at high concentrations. In other words, it can be seen that the taxa extract has a synergistic effect on the production of nitrogen monoxide (NO) induced by IFN-γ at high concentrations such as 1000 µg / µl.

택사 추출물이 대식세포주 RAW 264.7의 일산화질소 생산에 미치는 영향Effects of Taxa Extracts on Nitric Oxide Production in Macrophage Cell RAW 264.7 택사 추출물Taxa Extract 자 극 제Stimulant 00 LPS(1㎍/㎖)LPS (1 μg / ml) IFN-γ(1ng/㎖)IFN-γ (1 ng / ml) 00 4.17±1.574.17 ± 1.57 3.81±1.253.81 ± 1.25 5.47±1.745.47 ± 1.74 1One 2.90±0.132.90 ± 0.13 3.12±0.083.12 ± 0.08 2.86±0.232.86 ± 0.23 1010 2.87±0.242.87 ± 0.24 2.66±0.192.66 ± 0.19 3.50±0.203.50 ± 0.20 100100 3.02±0.103.02 ± 0.10 3.02±0.713.02 ± 0.71 6.43±0.016.43 ± 0.01 10001000 4.49±1.474.49 ± 1.47 5.87±2.625.87 ± 2.62 21.44±3.0421.44 ± 3.04 〔주〕택사 추출물 단위: ㎍/㎖Taxa extract unit: µg / ml

택사 추출물이 동종항원에 의한 증식반응에 미치는 효과를 조사한 결과, 도9a에 나타낸 바와 같이 동일한 표적세포의 수(5×105cells/well)일 때 효과세포의 수가 well당 1×106cells이 배양 후 3일째에 최대 증식반응을 나타내었다. 따라서, 동일한 조건에서 0.01, 0.1, 1, 10㎍/㎖의 택사 추출물을 같이 처리하여 배양 후 3일째 증식반응을 측정한 결과, 도 9b에 나타낸 바와 같이 택사 추출물의 농도 의존적으로 동종항원에 대한 증식반응이 억제되는 것을 알 수 있었다. 즉, 1㎍/㎖에서 최대 약 50% 정도의 증식 억제효과를 나타내었다.As a result of investigating the effect of taxa extract on the proliferative response by homologous antigen, as shown in FIG. 9A, when the same number of target cells (5 × 10 5 cells / well), the number of effect cells was 1 × 10 6 cells per well. Maximum proliferative response was seen at 3 days after culture. Therefore, as a result of measuring the proliferative response on day 3 after cultivation by treating 0.01, 0.1, 1, 10 ㎍ / ml taxa extract under the same conditions, as shown in FIG. It was found that the reaction was suppressed. That is, it showed a growth inhibitory effect of about 50% at 1 μg / ml.

T세포가 생산하는 사이토카인(cytokine)의 생산량을 측정한 결과, 표 3에 나타낸 바와 같이 동종항원에 대해 반응하는 T세포는 IL-2, IL-10 및 IFN-γ 등을 생산하였지만, 택사 추출물을 첨가한 실험군에서 IL-2, IFN-γ 및 IL-10의 생산량이 억제됨을 알 수 있었다. 따라서, 택사 추출물은 동종항원에 대해 반응하는 T세포의 사이토카인(cytokine) 생산을 억제함으로써 분열 증식을 저해하는 것으로 생각된다.As a result of measuring the amount of cytokines produced by T cells, T cells responding to homologous antigens produced IL-2, IL-10 and IFN-γ, as shown in Table 3. It was found that the production of IL-2, IFN-γ and IL-10 was suppressed in the experimental group added. Therefore, it is thought that the taxa extract inhibits cleavage proliferation by inhibiting cytokine production of T cells in response to homologous antigens.

택사 추출물이 동종항원에 대해 반응하는 T세포의 사이토카인 분비에 미치는 영향Effects of Taxa Extracts on Cytokine Secretion of T Cells Responding to Homologous Antigens 실험 조건Experimental conditions 사이토카인(cytokines)Cytokines IL-2IL-2 IFN-γIFN-γ IL-4IL-4 IL-10IL-10 T 세포T cell <10<10 94.3±17.294.3 ± 17.2 <10<10 200.0±21.2200.0 ± 21.2 T 세포+ 비장T cell + spleen 372.4±4.2372.4 ± 4.2 644.3±12.1644.3 ± 12.1 104±13.3104 ± 13.3 430.0±148.5430.0 ± 148.5 T 세포+비장+택사 추출물T Cell + Spleen + Taxa Extract 316.4±3.7316.4 ± 3.7 422.9±23.2422.9 ± 23.2 <10<10 205.0±70.7205.0 ± 70.7 〔주〕사이토카인 단위: pg/㎖(Note) Cytokine Unit: pg / ml

택사 추출물이 동종항원에 대한 T세포의 살세포작용에 미치는 영향을 조사한결과, 도 10에 나타낸바와 같이 동종항원에 대한 T세포의 살세포 작용을 택사 추출물이 저농도인 1㎍/㎖에서 완전히 억제함을 알 수 있었다. 따라서, 택사 추출물은 동종항원에 대한 T세포의 사이토카인(cytokine) 생산량을 억제함으로써 분열증식을 억제하였고, T세포의 동종항원에 대한 살세포 작용도 억제하는 것으로 나타났다.As a result of investigating the effect of taxa extract on T cell apoptosis on allogeneic antigen, as shown in FIG. 10, T. agar extract completely inhibited T cell apoptosis on homologous antigen at low concentration of 1㎍ / ml And it was found. Therefore, the extract of Taeksa inhibited the proliferation by inhibiting the cytokine production of T cells against homologous antigens, and also inhibited the killer cell activity against homologous antigens of T cells.

실시예 1: 본 발명 택사발효주의 제조Example 1: Preparation of the present invention fermented liquor

제 1공정: 흑국균의 배양1st step: cultivation

원료 쌀을 씻어 80g을 물에 2시간정도 담근 후 1시간정도 절수과정을 거쳤다. 상기 불린 쌀을 시루등에 넣고 1시간정도 증자하였다. 증자 쌀은 덩어리를 없앤후 35℃정도로 냉각하여 흑국균(Aspergillus awamori)를 접종하여 45℃에서 48시간 배양함으로써 코지(koji)를 제조하였다. 본 공정의 코지 제조의 목적은 쌀에 효모를 번식시켜 효소를 생산하게 함을 목적으로 한다.The raw rice was washed, soaked 80g in water for 2 hours and then water-saved for 1 hour. The soaked rice was put in a see-through lamp and the mixture was increased for about 1 hour. The steamed rice was removed by lumps and cooled to about 35 ° C., inoculated with black pepper ( Aspergillus awamori ), and incubated at 45 ° C. for 48 hours to prepare koji. Cozy production of this process aims to produce yeast by breeding yeast in rice.

제 2공정: 1차 발효Second Process: Primary Fermentation

발효주 제조를 위한 2차 발효를 활발히 진행하기 위하여 효모를 배양증식하여 주모를 제조하였다. 즉, 제1공정에서 제조한 코지(koji) 80g에 물 104g 가하고 효모(Saccharomyces cereviceae)를 18ml접종하여 48시간동안 발효하여 주모를 제조하였다.In order to actively proceed the secondary fermentation for the production of fermented liquor was cultured and yeast was prepared juju. That is, 104 g of water was added to 80 g of koji prepared in the first step, and 18 ml of yeast ( Saccharomyces cereviceae ) was inoculated to ferment for 48 hours to prepare a main hair .

제 3공정: 2차 발효Third Process: Secondary Fermentation

택사 80g을 2시간동안 물에 불린 뒤 1시간 동안 절수한 후 증자하였다. 상기 증자한 택사 80g에 물 200ml을 첨가하고 제 2공정에서 제조한 1차 발효물인 주모를 함께 넣어 30℃에서 6일간 발효하였다. 발효가 종결된후, 여과하여 여액을 획득하고 이를 0.45 여과지(membrane filter)를 사용하여 제균한 뒤 도 11에 나타낸 바와 같이 제품화하였다.80 g of the taxi was soaked in water for 2 hours and then water-saved for 1 hour and then increased. 200 g of water was added to 80 g of the increased taxa, and the primary fermentation product prepared in the second step was added together and fermented at 30 ° C. for 6 days. After the fermentation was terminated, the filtrate was obtained by filtration and sterilized using 0.45 membrane filter and then commercialized as shown in FIG. 11.

실험예 4: 본 발명 택사발효주의 발효중 알콜함량의 변화Experimental Example 4 Change of Alcohol Content during Fermentation

배양한 흑국으로 1차 발효를 완료한 주모와 택사를 혼합하여 2차 발효를 실시하는 동안 알콜함량의 변화를 조사하였다. 알콜 정량은 시료 100ml을 정확하게 취하여 증류플라스크에 넣어 증류액이 메스플라스크에 약 70ml(20분 정도) 받아지면 증류를 마쳤다. 증류를 마친 시료는 증류수를 가해 100ml 되게 한 다음 흔들어서 잘 혼합한 뒤 15℃정도 되면 주정계로 알콜함량(용량 %)을 측정하였다. 15℃에서 주정계로 잴 수 없을 때는 주정도 온도보정표를 사용하여 보정하였다. 실험 결과, 도 12에 나타낸바와 같이 알콜함량이 처음 3%이었던 것이 발효기간이 지남에 따라 알콜함량이 증가하여 발효 6일째에는 9.1%까지 되었으며 그 이후에는 변화가 없었다.The changes of alcohol content during the second fermentation were investigated by mixing the primary and fermented talc with the fermented black soup. Alcohol quantification was performed by accurately taking 100 ml of the sample and placing it in a distillation flask when the distillate received about 70 ml (about 20 minutes) into the volumetric flask. After distilled water was added to distilled water to make 100ml, shake well and mix well, and after about 15 ℃, alcohol content (volume%) was measured by alcohol. When it could not be found at 15 ℃, it was calibrated using the temperature calibration table. As a result, as shown in FIG. 12, the alcohol content of the first 3% was increased as the alcohol content increased over the fermentation period, reaching 9.1% on the 6th day of fermentation, and thereafter, there was no change.

실험예 5: 본 발명 택사발효주의 발효중 이산화탄소(COExperimental Example 5 Carbon Dioxide (CO) during Fermentation 22 )발생량의 변화Change in generation

택사발효주의 2차 발효 기간중 이산화탄소 발생량의 변화를 조사하였다. 이산화탄소 발생량은(이산화탄소 측정방법을 명시해주시기 바랍니다.)사용하여 측정하였다.Changes in carbon dioxide emissions during the second fermentation of liquefied liquor were investigated. Carbon dioxide generation (please specify the carbon dioxide measurement method) was measured using.

실험결과, 도 13에 나타낸 바와 같이 택사발효주의 2차 발효 기간 중 이산화탄소(CO2)발생량은 처음 3.2g/80g이었던 것이 발효기간이 경과됨에 따라 점차 증가하여 발효 6일째에는 14.98g/80g이 되었으며, 그 이후에는 변화가 거의 없었다.As a result, as shown in FIG. 13, the amount of carbon dioxide (CO 2 ) generated during the second fermentation period of the ethanol of the taxi was 3.2g / 80g, and gradually increased as the fermentation period elapsed, and became 14.98g / 80g on the 6th day of the fermentation. There has been little change since then.

실험예 6: 본 발명 택사발효주의 발효중 총산 함량의 변화Experimental Example 6: Change of Total Acid Content during Fermentation

택사발효주의 2차 발효 기간 중 총산을 정량하였다. 총산 정량은 시료 10ml를 0.1N-NaOH로 적정하여 호박산으로 환산하였다. 실험 결과, 도 14에 나타낸바와 같이 총산 함량은 처음 0.07%이었던 것이 발효기간이 경과됨에 따라 점차 증가하여 발효 6일째에는 0.19%가 되었으며, 그 이후에는 변화가 거의 없었다.The total acidity was quantified during the second fermentation period of the taxi fermentation strains. Total acid quantification was converted to succinic acid by titrating 10 ml of the sample with 0.1N-NaOH. As a result, as shown in FIG. 14, the total acid content, which was 0.07% for the first time, gradually increased as the fermentation period elapsed, and became 0.19% on the 6th day of fermentation, and there was little change thereafter.

실험예 7: 본 발명 택사발효주의 발효중 환원당과 유리당 함량의 변화Experimental Example 7: Changes of Reducing Sugars and Free Sugars in Fermentation

택사발효주의 2차 발효기간 중 환원당과 유리당 함량의 변화를 조사하였다. 환원당함량은 DNS법으로 정량하여 포도당 양으로 환산하여 나타내었다. 또한 유리당함량은 일정량의 시료를 3000rpm, 20분간 원심분리한 다음 그 상징액을 0.25㎛ 필터로 막여과하였다. 상기 여과액을 Sep-Pak C18카트리지(cartidge)에 통과시켜 색소와 고분자 물질을 제거한 후 HPLC로 분석하였다. HPLC분석시 표준당은 0.5%의 포도당, 과당 및 자당의 특급용액을 사용하였으며, 시료 피크(peak) 면적과 표준당피크(peak) 면적을 비교환산하여 시료중의 당류함량을 계산하였다. 실험 결과, 환원당 함량은 도 15에 나타낸바와 같이 본 발명 택사발효주의 2차 발효 초기에 7.1%이었던 것이 발효기간이 경과됨에 따라 점차 감소하여 발효 6일째에는 1.9%가 되었으며, 그 이후에는 변화가 거의 없었다. 본 발명 택사발효주의 유리당 분석 결과, 도 16에 나타낸 바와 같이 대부분이 포도당이었고, 그외에는 맥아당, 과당 및 설탕을 미량 함유하고 있었으며 2차 발효기간중 그 함량은 발효 초기에 비하여 모두 감소하였는데 포도당의 경우는 발효 6일째에 처음 0.53%에서 0.3%로 감소하였다. 그외의 나머지 유리당은 아주 미량이었다.The changes of reducing sugar and free sugar contents were investigated during the second fermentation of liquefied liquor. Reducing sugar content was quantified by the DNS method and expressed in terms of glucose. In addition, the content of free sugar was centrifuged at 3000 rpm for 20 minutes for a certain amount of the sample, and the supernatant was membrane filtered with a 0.25 μm filter. The filtrate was passed through a Sep-Pak C 18 cartridge (cartidge) to remove the pigment and polymer material was analyzed by HPLC. For HPLC analysis, 0.5% of glucose, fructose and sucrose were used as a special solution, and the sample peak area and the standard sugar peak area were compared and the sugar content in the sample was calculated. As a result, as shown in Figure 15, the reducing sugar content was 7.1% at the beginning of the second fermentation of the present invention fermentation liquor of the present invention gradually decreased with the passage of the fermentation period and became 1.9% on the 6th day of fermentation, after which almost no change was observed. There was no. As a result of free sugar analysis of the present invention fermentation liquor, as shown in FIG. 16, most of the glucose was, and other than that contained a small amount of maltose, fructose and sugar, the content of the second fermentation period was lower than the initial fermentation, but in the case of glucose Was decreased from 0.53% to 0.3% at 6 days of fermentation. The rest of the free sugar was very small.

실험예 8: 본 발명 택사발효주의 유기산 함량Experimental Example 8: Organic Acid Content of the Talc Fermented Wine of the Invention

본 발명 택사발효주의 유기산 함량의 분석은 시료를 헥산(hexane)으로 유지성분을 제거하고 0.45㎛ 필터(membrane filter)로 막여과한 후 Sep-pak C18로 색소 및 단백질성분을 제거하여 HPLC로 분석하였다. 실험 결과, 본 발명 택사발효주의 유기산은 표 4에 나타낸 바와 같이 호박산(Succinic acid)와 젖산(Lactic acid)의 함량이 각각 54.8, 15.7mg%로 많은 양이 존재하였고, 구연산(Citric acid)와 사과산(Malic acid)은 각각 13.2, 15.7mg%로서 호박산과 젖산에 비해 상대적으로 작게 검출되었다.In the present invention, the organic acid content of the fermented liquor was analyzed by HPLC by removing the oil and fat components with hexane, membrane filtration with a 0.45 μm filter, and removing the pigment and protein components with Sep-pak C 18 . It was. As a result, the organic acid of the present invention fermented liquor was present in a large amount of succinic acid and lactic acid as 54.8 and 15.7 mg%, respectively, as shown in Table 4, citric acid and malic acid. (Malic acid) was 13.2 and 15.7 mg%, respectively, which was relatively small compared to succinic acid and lactic acid.

본 발명 택사발효주의 유기산 함량Organic Acid Content of the Talc Fermented Wine of the Invention 유기산Organic acid 구연산Citric acid 사과산Malic acid 호박산Succinic acid 젖산Lactic acid 함량content 13.213.2 15.715.7 54.854.8 56.756.7 〔보기〕단위 mg%[Example] unit mg%

실험예 10: 본 발명 택사발효주의 무기성분 함량Experimental Example 10: Inorganic Component Content of Talc Fermented Wine of the Present Invention

본 발명 택사발효주의 2차발효중의 무기성분의 함량의 분석은 시료용액 100㎖에 분해제(HClO4:H2SO4:H2O2=9:2:5, v/v) 25㎖를 가하여 낮은 온도에서 서서히 가열하여 완전하게 무색으로 변할 때 까지 핫 플래이트(Hot plate)에서 분해한 후 와트만 2(Whatman No. 2) 여과지를 사용하여 여과하였다. 상기 여과액을 100㎖로 정용한 뒤 ICP를 사용하여 분석하였다. 실험 결과, 표 5에 나타낸 바와 같이 본 발명 택사발효주의 총 무기성분 함량은 41.15ppm이었으며, 그중 칼륨(K)의 함량이 22.30ppm으로 가장 많았다. 다음으로는 칼슘(Ca)의 함량이 18.51ppm으로 많았으며, 나머지는 미량이었다.The analysis of the content of the inorganic component in the second fermentation of the taxi fermentation strain of the present invention was carried out in 100 ml of the sample solution, 25 ml of a decomposition agent (HClO 4 : H 2 SO 4 : H 2 O 2 = 9: 2: 5, v / v). The solution was slowly heated at low temperature, decomposed in a hot plate until completely colorless, and filtered using Whatman No. 2 filter paper. The filtrate was normalized to 100 ml and analyzed using ICP. As a result, as shown in Table 5, the total inorganic component content of the present invention fermented liquor was 41.15 ppm, and the content of potassium (K) was the most as 22.30 ppm. Next, the content of calcium (Ca) was 18.51 ppm, and the rest was trace amount.

본 발명 택사발효주의 무기성분 함량Inorganic Component Content of Taxa Fermented Wine of the Present Invention 무기 성분Inorganic ingredients 칼슘(Ca)Calcium (Ca) 칼륨(K)Potassium (K) 마그네슘(Mg)Magnesium (Mg) 철 (Fe)Iron (Fe) 구리 (Cu)Copper (Cu) 총량Total amount 함량content 18.5118.51 22.3022.30 3.303.30 0.970.97 0.070.07 45.1545.15 〔주〕단위: ppm(Note) Unit: ppm

실험예 11: 본 발명 택사발효주의 유리아미노산 함량Experimental Example 11: Free amino acid content of the present invention

본 발명 택사발효주의 유리아미노산 함량의 변화를 조사하였다. 유리아미노산의 분석은 시료 10㎖에 에탄올(ethanol) 30㎖를 가한 다음 하룻밤 실온에 방치시켜 단백질을 침전 제거한 다음 상징액을 3000rpm에서 10분간 원심분리한후 상징액만 위하여 중탕 가열하여 건고시켰다. 상기 건고시킨 상징액에 pH2.2의 구연산 완충용액(citrate buffer) 10㎖를 가하여 희석한 후 0.45㎛ 필터로 여과한 여액을 아미노산 자동분석기로 분석하였다. 실험 결과, 표 6에 나타낸바와 같이 본 발명 택사발효주의 총 유리아미노산 함량은 385.33mg%였고, 유리아미노산 중 글루탐산(glutarmic acid), 아르기닌(arginine), 프롤린(proline), 루신(leucine), 발린(valine) 및 알라닌(alanine) 함량이 각각 43.52, 38.43, 36.98, 36.57, 35.20 및 34.23mg%로 나타났으며 히스티딘(histidine)의 경우 그 함량이 9.32mg%로 가장 적게 검출되었다.The change in the free amino acid content of the present invention fermented liquor was investigated. In the analysis of free amino acid, 30 ml of ethanol was added to 10 ml of the sample, and the protein was allowed to settle overnight at room temperature. The dried supernatant was diluted by adding 10 ml of citric acid buffer (citrate buffer) at pH 2.2, and the filtrate was filtered with a 0.45 μm filter. As a result, as shown in Table 6, the total free amino acid content of the present invention fermented liquor was 385.33 mg%. valine) and alanine contents were 43.52, 38.43, 36.98, 36.57, 35.20 and 34.23 mg%, respectively. Histidine was the lowest detected as 9.32 mg%.

본 발명 택사발효주의 유리아미노산 함량Free amino acid content of the present invention fermented liquor 피크 넘버(peak no)Peak number 아미노산(amino acid)Amino acid RTRT 함량content 1One 트레오닌(Threonine)Threonine 28.05028.050 14.0614.06 22 세린(Serine)Serine 29.72529.725 20.0620.06 33 아스파르트 산(Aspartic acid)Aspartic acid 32.98332.983 24.5024.50 44 글루탐산(Glutamic acid)Glutamic acid 34.62534.625 43.5243.52 55 프롤린(Proline)Proline 47.96747.967 36.9836.98 66 글리신(Glycine)Glycine 49.46749.467 27.3427.34 77 알라닌(Alanine)Alanine 50.97550.975 34.2334.23 88 발린(Valine)Valine 56.62556.625 35.2035.20 99 이소루신(Isoleucine)Isoleucine 70.95070.950 21.6921.69 1010 루신(Leucine)Leucine 73.52573.525 36.5736.57 1111 티로신(Tyrosine)Tyrosine 80.73380.733 24.7424.74 1212 리신(Lysine)Lysine 111.750111.750 18.6918.69 1313 히스티딘(Histidine)Histidine 115.042115.042 9.329.32 1414 알기닌(Arginine)Arginine 129.800129.800 38.4338.43 총 량 385.33Total volume 385.33 〔주〕단위 mg%[Note] unit mg%

실시예 2: 본 발명 택사발효주의 관능평가Example 2: sensory evaluation of the present invention fermentation strain

본 발명 택사발효주에 대한 관능평가를 실시하였다. 관능평가는 순천대학교 식품영양학교 대학생 및 대학원생 20명으로 구성된 관능요원이 색, 향, 쓴맛, 단맛 및 전체적인 맛을 최상을 5점, 최하를 1점으로 채점하여 평균치로 표시하는 5점법으로 채점하였다. 실험 결과, 도 17에 나타낸바와 같이 본 발명 택사발효주의 색과 향은 모두 좋은 결과를 나타내었다. 그러나 쓴맛이 강하게 나타나 5%의 설탕을 첨가하였고 그 결과 쓴맛이 감소되고 단맛이 증가하여 전체적으로 맛이 높게 나타났다.The sensory evaluation of the present invention fermented liquor was performed. In the sensory evaluation, sensory personnel, composed of 20 college students and graduate students of the School of Food and Nutrition, Sunchon National University, were scored by the five-point method, which scored the best, five points, the lowest, and one point for color, aroma, bitterness, and overall taste. . As a result of the experiment, as shown in FIG. 17, both the color and the fragrance of the present invention fermentation liquor showed good results. However, bitter taste was strong and 5% of sugar was added. As a result, bitterness was decreased and sweetness was increased.

이상, 상기 실시예를 통하여 설명한 바와 같이 본 발명 항균활성, 항산화효과 및 면역활성이 뛰어난 택사를 증자한 후 주모를 접종하여 발효함으로써 택사향이 그대로 담긴 색과 맛이 우수한 택사발효주를 제공하는 효과가 있으므로 본 발명은 양조 산업상 매우 유용한 발명인 것이다.As described above, the present invention has an effect of providing a tax fermentation liquor having excellent color and taste by inoculating fermented with sackcloth after increasing the antimicrobial activity, antioxidant effect, and immune activity of the present invention. The present invention is a very useful invention in the brewing industry.

Claims (2)

(a) 쌀을 불린 후에 절수하고 증자한 뒤 흑국균(Aspergillus awamori)를 접종하여 30∼55℃에서 배양함으로써 코지(koji)를 제조하는 단계;(b) 상기 (a)단계의 코지에 급수한 다음 효모를 접종하고 1차 발효하여 주모를 제조하는 단계; (c) 택사를 불린 후 절수하고 증자한 다음 상기 (b)단계의 1차 발효물과 물을 혼합하여 20∼40℃에서 2차발효를 한 뒤 여과하고 제균한후 설탕을 2∼7%첨가하여 제품화하는 단계로 구성됨을 특징으로 하는 택사발효주 제조방법.(a) after the rice is soaked, water-saving and increasing the inoculation of inoculated Asukgill bacteria ( Aspergillus awamori ) to incubate at 30-55 ℃ to prepare a koji (b) watering the koji of step (a) Then inoculating yeast and subjecting it to primary fermentation to produce a hair seed; (c) After calling the texas, water is saved, and then the mixture is mixed with the primary fermented product and water of step (b), and then fermented at 20 to 40 ℃ for secondary fermentation, followed by filtration and sterilization. Taxa fermentation liquor manufacturing method characterized in that consisting of the step of forming a product. 제 1항의 방법에 의해 제조되고 알콜함량이 8∼10%임을 특징으로 하는 택사발효주.A fermented liquor according to claim 1, characterized in that the alcohol content is 8 to 10%.
KR1020000078051A 2000-12-18 2000-12-18 Alismatis Rhizoma fermented wine and process for prepatration therof KR20020048778A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020000078051A KR20020048778A (en) 2000-12-18 2000-12-18 Alismatis Rhizoma fermented wine and process for prepatration therof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020000078051A KR20020048778A (en) 2000-12-18 2000-12-18 Alismatis Rhizoma fermented wine and process for prepatration therof

Publications (1)

Publication Number Publication Date
KR20020048778A true KR20020048778A (en) 2002-06-24

Family

ID=27682981

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020000078051A KR20020048778A (en) 2000-12-18 2000-12-18 Alismatis Rhizoma fermented wine and process for prepatration therof

Country Status (1)

Country Link
KR (1) KR20020048778A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030085987A (en) * 2002-05-03 2003-11-07 안치엽 Manufacture method of edible perfume
CN103173379A (en) * 2011-12-22 2013-06-26 熊津食品有限公司 Novel microbe for red ginseng fermentation, red ginseng fermentation liquid using the microbe and red ginseng fermentation drink
KR101280085B1 (en) * 2011-03-17 2013-06-28 하이트진로 주식회사 Preparation method of rice wine which includes microorganism removing step of supernatant of mash by non-heat treatment
EP2446754A4 (en) * 2009-06-25 2014-01-22 Kirin Holdings Kk Fermentation product of a cereal-derived material and immunomodulator

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030085987A (en) * 2002-05-03 2003-11-07 안치엽 Manufacture method of edible perfume
EP2446754A4 (en) * 2009-06-25 2014-01-22 Kirin Holdings Kk Fermentation product of a cereal-derived material and immunomodulator
KR101280085B1 (en) * 2011-03-17 2013-06-28 하이트진로 주식회사 Preparation method of rice wine which includes microorganism removing step of supernatant of mash by non-heat treatment
CN103173379A (en) * 2011-12-22 2013-06-26 熊津食品有限公司 Novel microbe for red ginseng fermentation, red ginseng fermentation liquid using the microbe and red ginseng fermentation drink

Similar Documents

Publication Publication Date Title
TWI543706B (en) The method for culturing antrodia cinnamomea
US9827213B2 (en) Astragalus membranaceus fermentation product and method of producing the same
KR101871247B1 (en) Functional grain syrup containing prunus mume extract and preparing method thereof
KR100844185B1 (en) The manfacturing method of fermentation artemisia tea with lactic acid
KR101338278B1 (en) Brew method of Korea rice wine
KR20120077581A (en) Method manufacture rice makgulli use estern prickly pear
KR101806812B1 (en) Method for producing water-clear Makgeolli using shiitake, cinnamon, plum and ginger
KR101984400B1 (en) Process for producing antioxidant and anti-fatigue efficacy of mulberry vinegar
KR20020048778A (en) Alismatis Rhizoma fermented wine and process for prepatration therof
KR102050663B1 (en) Manufacturing method of makgeolli containing cockscomb extract
CN107151618B (en) High flavonoids applejack of sweet tea high type and preparation method thereof
Song et al. Physicochemical properties, antioxidant activity and inhibition of α‐glucosidase of a novel fermented pepper (C apsiccum annuum L.) leaves‐based vinegar
KR20180106968A (en) Herb vinegar and manufacturing method thereof
KR20100081625A (en) Method for preparing sponge gourd vinger from luffa cylindrica l
CN114246310A (en) Direct-vat probiotic fermented capsicum frutescens and preparation method thereof
KR102089045B1 (en) A fermented grain and method fot preparing thereof
KR100440493B1 (en) Healthy drink comprising Alismatis Rhizoma extract and process for prepatration therof
KR101172621B1 (en) The manufacturing method of cucumber vinegar having anti-hangover functional
KR100998246B1 (en) Preparation Method of Kimchi Using Extract of Houttuynia cordata Thunb and Saururus chinensis Baill
CN107118900B (en) Do soft high flavonoids applejack of type and preparation method thereof
KR100392775B1 (en) Alismatis Rhizoma tea of rosted type and process for prepatration thereof
KR20100135575A (en) Method for processing enhanced health functional tradition rice wine using opuntia humifusa and product thereof
KR100392277B1 (en) Alismatis Rhizoma tea of granule type and process for prepatration therof
KR102201242B1 (en) Fermented milk using Cordyceps militaris grown upon Tenebrio molitor and preparation method thereof
De Souza et al. Physical-Chemical Characterization of Fermented Coconut Water (Cocos nucifera L)

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application